ConductScience.org, home

Paper34201655

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.

Shklovskaya E and 1 other. Int J Mol Sci, 2021. Cited by 58 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It. Papers, record 34201655. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34201655

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.99
iCite
Revised in PubMed
2021-08-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shklovskaya EElena
2Rizos HHelenhttps://orcid.org/0000-0002-2094-9198

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Histocompatibility Antigens Class IMajor topic
NeoplasmsMajor topic
Tumor EscapeMajor topic
Animals
CD4-Positive T-Lymphocytes
Down-Regulation
Humans
Immunotherapy
Killer Cells, Natural
Mutation

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
1128951; 1130423National Health and Medical Research Council of AustraliaPubMed

Source PubMed

References347

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,727,458Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.J Exp Med2000https://conductscience.org/library/papers/10727458PubMed
231,810,126Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.Biomed Pharmacother2020https://conductscience.org/library/papers/31810126PubMed
328,512,174Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.Clin Cancer Res2017https://conductscience.org/library/papers/28512174PubMed
411,117,911Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population.Lancet2000https://conductscience.org/library/papers/11117911PubMed
532,524,362IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.Cancer Immunol Immunother2020https://conductscience.org/library/papers/32524362PubMed
622,645,137Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.J Biol Chem2012https://conductscience.org/library/papers/22645137PubMed
728,983,798Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.Adv Ther2017https://conductscience.org/library/papers/28983798PubMed
829,301,958A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.Science2018https://conductscience.org/library/papers/29301958PubMed
919,883,394Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.Tissue Antigens2010https://conductscience.org/library/papers/19883394PubMed
1032,355,214Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity.Sci Rep2020https://conductscience.org/library/papers/32355214PubMed
1122,383,801Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.Blood2012https://conductscience.org/library/papers/22383801PubMed
1229,388,200Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.Int J Cancer2018https://conductscience.org/library/papers/29388200PubMed
1328,408,606Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.Science2017https://conductscience.org/library/papers/28408606PubMed
1410,894,167CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.Immunity2000https://conductscience.org/library/papers/10894167PubMed
1520,625,726The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible "hard" lesions.Cancer Immunol Immunother2010https://conductscience.org/library/papers/20625726PubMed
1619,002,680NetMHCpan, a method for MHC class I binding prediction beyond humans.Immunogenetics2009https://conductscience.org/library/papers/19002680PubMed
1731,564,637An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.Cancer Cell2019https://conductscience.org/library/papers/31564637PubMed
1833,827,917Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/33827917PubMed
1925,409,260Genetic basis for clinical response to CTLA-4 blockade in melanoma.N Engl J Med2014https://conductscience.org/library/papers/25409260PubMed
2029,107,330Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.Cell2017https://conductscience.org/library/papers/29107330PubMed

See all 347 references

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
42,985,562HLA class I and II polymorphisms in pediatric neuroblastoma: mechanistic links to immune surveillance, tumor evolution, and clinical translation.Front Genet2026https://conductscience.org/library/papers/42985562PubMed
42,954,362Neoadjuvant Therapy for Non-Small Cell Lung Cancer: Recent Advances and Future Directions.Cancer Med2026https://conductscience.org/library/papers/42954362PubMed
42,798,230Selinexor potentiates NK cell activation against multiple myeloma.Clin Exp Immunol2026https://conductscience.org/library/papers/42798230PubMed
42,588,678The Central Role of HLA Class II-Restricted Helper Neoantigen Vaccines in Cancer Immunotherapy.Cancers (Basel)2026https://conductscience.org/library/papers/42588678PubMed
42,346,099The Architecture of Immune Escape in Neuroblastoma: Plasticity, Silence and Escape Engineer Immune Blindness.Cells2026https://conductscience.org/library/papers/42346099PubMed
42,331,945Two-way tuning of the decidual natural killer cells and recurrent pregnancy loss.Sci Rep2026https://conductscience.org/library/papers/42331945PubMed
42,287,670Role of the Proteasome System in Shaping Cellular Immunological Characteristics and Its Impact in Modulating the Pathogenesis of Immune-Related Diseases.Cells Tissues Organs2026https://conductscience.org/library/papers/42287670PubMed
41,750,317Advances in Next-Generation Immunotherapies for Ovarian Cancer: Mechanisms of Immune Evasion and Novel Therapeutic Targets.Biomolecules2026https://conductscience.org/library/papers/41750317PubMed
41,437,275Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5.J Transl Med2025https://conductscience.org/library/papers/41437275PubMed
41,410,712Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING.Cancer Immunol Immunother2025https://conductscience.org/library/papers/41410712PubMed
41,346,595Immune checkpoint inhibitors in melanoma: mechanisms, immune cell interactions, and the tumour microenvironment.Front Immunol2025https://conductscience.org/library/papers/41346595PubMed
41,292,152Tumor Microenvironments in Malignant Ovarian Germ Cell Tumors: MHC Class I Loss and T-Cell Exhaustion in Dysgerminoma.Cancer Sci2026https://conductscience.org/library/papers/41292152PubMed
41,258,335Targeting prostate adenocarcinoma tumor microenvironment via cancer nanotheranostics: a comprehensive update on improved roadmap for disease diagnosis, therapy and management.Clin Transl Oncol2026https://conductscience.org/library/papers/41258335PubMed
40,673,641Decoding MHC loss: Molecular mechanisms and implications for immune resistance in cancer.Clin Transl Med2025https://conductscience.org/library/papers/40673641PubMed
40,575,168The efficacy and safety of chemoimmunotherapy in patients with MSI-L/MSS/pMMR status metastatic colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.Front Oncol2025https://conductscience.org/library/papers/40575168PubMed
40,431,665Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCC.Viruses2025https://conductscience.org/library/papers/40431665PubMed
40,269,245Fangchinoline-mediated autophagy inhibition amplifies antigen presentation and PD-1 blockade efficacy in lung cancer.Acta Pharmacol Sin2025https://conductscience.org/library/papers/40269245PubMed
40,227,782Beyond Adaptive Immunity: Trained Innate Immune Responses as a Novel Frontier in Hepatocellular Carcinoma Therapy.Cancers (Basel)2025https://conductscience.org/library/papers/40227782PubMed
40,098,955The potential applications of peptide-loading complex in cancer treatment.Front Immunol2025https://conductscience.org/library/papers/40098955PubMed
39,879,294One-dimensional nanosonosensitizer boosted multiple branches of immune responses against MHC-deficient immune-evasive urologic tumor.Sci Adv2025https://conductscience.org/library/papers/39879294PubMed

See all 47 cited by

Genes79

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ANKRD30A91,074PubTator's text mininghttps://conductscience.org/library/genes/91074NCBI Gene
ANPEP290PubTator's text mininghttps://conductscience.org/library/genes/290NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CALCA796PubTator's text mininghttps://conductscience.org/library/genes/796NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD22610,666PubTator's text mininghttps://conductscience.org/library/genes/10666NCBI Gene
CD24451,744PubTator's text mininghttps://conductscience.org/library/genes/51744NCBI Gene
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CIITA4,261PubTator's text mininghttps://conductscience.org/library/genes/4261NCBI Gene
CTLA41,493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CTNNB11,499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CXADRP1653,108PubTator's text mininghttps://conductscience.org/library/genes/653108NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERAP151,752PubTator's text mininghttps://conductscience.org/library/genes/51752NCBI Gene
ERAP264,167PubTator's text mininghttps://conductscience.org/library/genes/64167NCBI Gene
ERBB22,064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene

See all 79 genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34201655

GET https://conductscience.org/api/papers/v1/34201655/references?page=2